A Study of the Pharmacokinetics of Uprifosbuvir (MK-3682) and Ruzasvir (MK-8408) in Participants With Moderate and Severe Hepatic Insufficiency (MK-3682-029)
Condition(s):Hepatitis C, ChronicLast Updated:September 17, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Hepatitis C, ChronicLast Updated:September 17, 2018Completed
Condition(s):Hepatitis C, ChronicLast Updated:June 26, 2019Terminated
Condition(s):Hepatitis CLast Updated:February 2, 2021Terminated
Condition(s):Hepatitis CLast Updated:January 9, 2019Completed
Condition(s):Hepatitis; Hepatitis C; Digestive System Diseases; Flaviviridae Infections; Hepatitis, Viral, Human; Liver Diseases; RNA Virus Infections; Virus DiseasesLast Updated:July 26, 2019Terminated
Condition(s):Chronic Hepatitis CLast Updated:September 13, 2018Completed
Condition(s):Hepatitis CLast Updated:July 30, 2019Completed
Condition(s):Hepatitis CLast Updated:July 23, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.